0231U CPT® code: payer coverage and prior authorization0231U appears in 6 coverage policies from Aetna, Blue Cross & Blue Shield of Mississippi, Blue Cross & Blue Shield of Rhode Island, Blue Cross NC, Blue Shield of California, BlueCross BlueShield of South Carolina.
| Payer | Policy | Role in policy | Reviewed | Document |
|---|---|---|---|---|
| Aetna | Genetic Testing (0140) Genetic testing for dominant polycystic kidney disease (PKD1 and PKD2) | covered if criteria are met | Aug 18, 2026 | payer document |
| Blue Cross & Blue Shield of Mississippi | Genetic Testing (L.2.04.409) | covered if criteria are met | payer document | |
| Blue Cross & Blue Shield of Rhode Island | Genetic Testing for Epilepsy This code can be used for Genomic Unity® CACNA1A Analysis (Variantyx Inc) | covered if criteria are met | Mar 18, 2026 | payer document |
| Blue Cross NC | Genetic Testing for Neurodegenerative Disorders AHS – M2167 | listed, no stance | Oct 1, 2025 | payer document |
| Blue Shield of California | | Genetic Testing for Epilepsy (2.04.109) | listed, no stance | payer document | |
| BlueCross BlueShield of South Carolina | Genetic Testing for Neurodegenerative Disorders (CAM 234) Number | listed, no stance | Oct 1, 2025 | payer document |
Prior authorization required or conditional in IN, MS.
From payers' published prior-auth lists, coverage policies and state Medicaid fee schedules, updated Oct 16, 2026. The role is what the policy's own code table or text says about the code. Not a guarantee of coverage or payment; verify with the payer. CPT® is a registered trademark of the American Medical Association.